Molecular Immunology
- Home
- Molecular Immunology
MSCTR | Cancer Research |Translational Research
Over the last two decades there has been a paradigm shift in our perception of cancer therapy. As we know now, neoplasia do not consist only of transformed cells, but contain an abundant and heterogeneous non-transformed component like stromal, endothelial and immune cells. The host immune system can recognize and sometimes react against (pre-) malignant cells as they transform, proliferate and evolve. The knowledge laid the grounds of anticancer immunosurveillance leading to cancer immunotherapy. Recent intense wave of preclinical and clinical investigation culminated in approval of various immunotherapeutic interventions for use in humans. In 2013, the extraordinary clinical success of immunotherapy has won this new method of therapy the title of “Breakthrough of the Year”. Nonetheless, we have just begun to unravel the therapeutic possibilities offered by anticancer immunotherapy.
The following programs have been envisioned to yield a number of Therapeutic and Diagnostic Products and processes
Manjula Das, PhD Principal Investigator manjula.das@ms-mf.org
PhD from Indian Institute of Science with training from McGil University – Canada and MIT-USA during post doctoral studies Manjula has spent long years in the Industry. She is an expert in Biotherapeutics especially critical reagent and assay development (in vitro and in vivo) for regulatory submission of protein drugs. She also has established many companies, the latest being a consultancy firm named Beyond Antibody. Manjula with 20-years long market experience concentrates on translating basic research to products and processes for direct patient care in various areas of cancer.
Project Scientist I/ Consultant syedalubna@ms-mf.org
Project: Biologics product Development for Diagnosis ,Prognosis and theraphy
Senior Research Fellow sohini@ms-mf.org
Project: Targetting the LCN2 Niche in Fibroblast Mediated Diseases
Senior Research Fellow shashi.kumar@ms-mf.org
Project: IDH Mutations
Project Associate I shraddha@ms-mf.org
Project: Biologics product Development for Diagnosis ,Prognosis and theraphy
Junior Research Fellow rohit@ms-mf.org
Project: Biologics product Development for Diagnosis ,Prognosis and theraphy
ACTREC Mumbai
MSMC, NH
NH
Univ Dalhousie
IISc, Bangalore
MSMC, NH
IISc, Bangalore
Divya CA
Senior Research Fellow, divya.biotech82@gmail.com
Vishnupriyan
Junior Research Fellow, Department of Pathology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
Sreejeta Mandel
Junior Research Fellow,Syngene Intl
Sowmya
Junior Research Fellow,#51, Huntington Avenue, Scarborough, Toronto, Ontario, M1K4K9, Canada
Dr Smith P K
Senior Research Fellow, MSMF
Neha Damodar
Intern, MAHE
Lubna Syeda
Junior Research Fellow, Syeda Lubna, Ph.D student, Department of Biological Sciences, Birla Institute of Technology & Science – Pilani, Hyderabad campus , Hyderabad – 500078 +91 – 9739637786 syedalubna.official@gmail.com
Kartik Sachdeva
Junior Research Fellow
Pushkarni Suresh
Junior Research Fellow Univ McGill, Montreal
Gouri Raj
Junior Research Fellow Neuro-oncology, MSMF
Kunal Biswas
Junior Research Fellow Syngene Intl
Nidhi Shukla
Junior Research Fellow Syngene Intl
Nehanjali
PhD Student nehanjali.dwivedi@ms-mf.org, Nehanjali is a PhD student with MAHE whose work primarily focuses on the role of LCN2, an inflammatory marker in oral cancer and Immunotherapy
Christine Cherry
Junior Research Fellow
D N Shashank
Junior Research Fellow
Hafsa
Junior Research Fellow
Shashikumar T
Junior Research Fellow
Dr Arnob Chatterjee
Research Scientist
Shivansh Tyagi
PhD STUDENT